home / stock / cydy / cydy news


CYDY News and Press, CytoDyn Inc From 09/29/21

Stock Information

Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com

Menu

CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...

CYDY - CytoDyn Comments on Rosenbaum/Patterson Activist Group "Plan"

Company Is Successfully Executing on Multi-Faceted Strategy to Bring Leronlimab to Market Activist Group Offers No New Compelling Strategic Direction and its “Plan” Includes Numerous Misrepresentations and Misleading Statements Activist Group’s Con...

CYDY - Group of CytoDyn Stockholders Releases White Paper Regarding Company's Extremely Unfavorable Borrowing Practices

A group of long-time stockholders (the “Nominating Stockholders” or the “Group”) of CytoDyn Inc. (“CYDY or the “Company”) (OTC: CYDY) that has nominated five highly experienced director candidates to serve on the Company’s Board of...

CYDY - Making a Penny Stocks Watch List in October? Check These 3 Out

3 Penny Stocks to Watch in October 2021 With the month of October fast approaching, many investors are looking for the best penny stocks to buy. While it is still around a week or so away, being proactive can mean the difference between making money with penny stocks and losing mone...

CYDY - Group of CytoDyn Stockholders Shares Strategic Plan to Obtain Cancer Therapy Approval for Leronlimab

Plan Designed to Generate Much-Needed Revenue and Receive FDA Approval for Currently Mismanaged Drug B elieves Company Cannot Continue to Pursue Status Quo Strategy, Which Has Been Abjectly Discredited A group of long-time stockholders (the “Nominating Sto...

CYDY - Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants

Palm Beach, FL – September 22, 2021 – FinancialNewsMedia.com News Commentary – The U.S. government, via the American Rescue Plan, is investing more than $3 billion to accelerate the discovery, development and manufacturing of antiviral medicines as part of t...

CYDY - CytoDyn Receives Clearance from Brazil's FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)

CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that Brazil’s regulatory authority, ANVISA (Ag...

CYDY - CytoDyn's Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021

CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that Dr. Scott Kelly, CytoDyn’s Chairman of th...

CYDY - Group of CytoDyn Stockholders Announces Federal Court Dismisses Litigation Brought by Company

Nominating Stockholders Fully Committed to Proxy Contest and Electing Director Candidates A group of long-time stockholders (the “Nominating Stockholders” or the “Group”) of CytoDyn Inc. (“CYDY or the “Company”) (OTC: CYDY) th...

CYDY - Best Penny Stocks To Buy Today? Retail Traders Are Watching These Now

Are These Penny Stocks On your Watch List Today? Is the stock market safe? Whether you’re trading penny stocks or higher-priced names, it’s hard to ignore what’s transpired over the last week. The S&P, Nasdaq, Dow, and Small-Cap indexes have all pulled back. Tha...

CYDY - CytoDyn Announces Resolution of Federal Litigation with Rosenbaum/Patterson Activist Group

Activist Group Made Numerous Concessions, Including Dissolving Schedule 13D Group and Making Corrective and New Disclosures New Disclosures Clearly Show Activist Group Has Been Misleading Shareholders Around Group’s Conflicts of Interest, Sources of Funding and Agenda ...

Previous 10 Next 10